EARLY PRO-2 SYMPTOM REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY

William J. Sandborn  1     Tadakazu Hisamatsu  2     Kathleen Weisel  3     Susana Gonzalez  3     Mary Ellen Frustaci  3     Zijiang Yang  4     Jewel Johanns     Matthew Germinaro     Brian Feagan     Aniita Afzali     Walter Reinisch     Jane Andrews     Omoniyi J. Adedokun     Chenglong Han    
1 University of California San Diego,San Diego,United States
2 Kyorin University,Tokyo,Japan
3 Janssen Research & Development, LLC,Spring House,United States
4 Janssen Research & Development, LLC,S

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing